冬凌草甲素通过激活ERK途径诱导U937细胞凋亡Oridonin induced U937 cell apoptosis through ERK pathway
刘艳秋;游松;田代真一;小野寺敏;池岛乔;
LIU Yan-qiu~(1,2),YOU Song~(2),TASHIRO Shin-ichi~(3),ONODERA Satoshi~(3),IKEJIMA Takashi~(1)(1.China-Japan Research Institute of Medical and Pharmaceutical Sciences,Shenyang Pharmaceutical University,Shenyang 110016,China;2.Laboratory of Natural Product Biotechnology,Shenyang Pharmaceutical University,Shenyang 110016,China;3.Department of Clinical and Biomedical Sciences,Showa Pharmaceutical University,Machida,Tokyo 194-8543,Japan)
摘要(Abstract):
目的:研究冬凌草甲素诱导人组织淋巴瘤U937细胞凋亡的机制及ERK激酶在凋亡过程中的作用。方法:噻唑蓝(MTT)法,Hoechst 33258染色法,DNA凝胶电泳及Western blot检测法。结果:冬凌草甲素对U937细胞生长抑制作用呈时间剂量依赖性。27μmol.L-1冬凌草甲素作用细胞12 h后,Hoechst 33258染色细胞,出现明显凋亡小体,并诱导ERK发生磷酸化。ERK磷酸化抑制剂PD98059阻断了冬凌草甲素诱导的细胞生长抑制及DNA片段化。细胞内抑制凋亡蛋白Bcl-XL表达量时间依赖性减少,促凋亡蛋白Bax表达量增加,而ERK抑制剂可逆转这种作用。结论:冬凌草甲素(27μmol.L-1)诱导U937细胞凋亡,这种作用是通过活化ERK激酶,改变其下游Bax/Bcl-XL的表达比率,从而促进U937细胞发生凋亡。
Objective: To study the mechanisms of oridonin-induced U937 cell apoptosis,and to examine the role of ERK MAPK.Method: MTT,Hoechst 33258 staining,DNA agarose gel electrophoresis and Western blot analysis were used.Result: Oridonin inhibited U937 cell growth in a time-and dose-dependent manner.Apoptotic bodies were found with Hoechst 33258 staining after treatment with 27 μmol·L(-1) oridonin.Simultaneously,ERK phosphorylation was significant.ERK inhibitor PD98059 partially blocked the growth-inhibitory effect as well as DNA fragmentation.The expression of antiapoptotic mitochondrial protein Bcl-X_(L) decreased time-dependently,and that of proapoptotic protein Bax increased.However,PD98059 reversed the effect of oridonin on Bcl-X_(L) and Bax.Conclusion: Oridonin induces U937 cell apoptosis through activation of ERK and alteration of the ratio of Bax/Bcl-X_(L)
关键词(KeyWords):
冬凌草甲素;U937细胞;凋亡;ERK激酶
oridonin;U937 cells;apoptosis;ERK
基金项目(Foundation):
作者(Authors):
刘艳秋;游松;田代真一;小野寺敏;池岛乔;
LIU Yan-qiu~(1,2),YOU Song~(2),TASHIRO Shin-ichi~(3),ONODERA Satoshi~(3),IKEJIMA Takashi~(1)(1.China-Japan Research Institute of Medical and Pharmaceutical Sciences,Shenyang Pharmaceutical University,Shenyang 110016,China;2.Laboratory of Natural Product Biotechnology,Shenyang Pharmaceutical University,Shenyang 110016,China;3.Department of Clinical and Biomedical Sciences,Showa Pharmaceutical University,Machida,Tokyo 194-8543,Japan)
参考文献(References):
- [1]王筠,刘清芸,华海婴,等.冬凌草甲素诱导HL-60细胞凋亡.中国药理学通报,2001,17(4):402.
- [2]Osawa K,Yasuda H,Maruyama T,et al.Antibacterial trichorabdalditerpenes from Rabdosia Trichocarpa.Phytochemistry,1994,36(5):1287.
- [3]Zhang Y,Wang J,Lou L G,et al.Scavenging effect of oridonin onactive oxygen free radicals.Henan Medical Reserch,1999,8(2):100.
- [4]孙震晓,魏育林,赵天德,等.斑蝥素及去甲斑蝥素诱导人白血病K562细胞凋亡的细胞学研究.解剖学报,2000,31(1):56.
- [5]Suzuki K,Hino M,Kutsuna H,et al.Selective activation of p38Mitogen-ativated protein kinase in human neutrophils stimulated byIL-1β.J Immunol,2001,167(10):5940.
- [6]Hayakawa J,Ohmichi M,Kurachi H,et al.Inhibition of extracellu-lar signal-regulated protein kinase or c-Jun N-terminal protein kinasecascade,differentially activated by cisplatin,sensitizes human ovari-an cancer cell line.J Biol Chem,1999,274(44):31648.
- [7]Wang X,Martindale J L,Holbrook N J,Requirement for ERK acti-vation in cisplatin-induced apoptosis.J Biol Chem,2000,275(50):39435.
- [8]Zhang C L,Wu L J,Zuo H J,et al.Oridonin induces a caspase-in-dependent but mitochondria-and MAPK-dependent cell death in themurine fibrosarcoma cell line L929.Biol Pharm Bull,2004,27(10),1527.
- [9]Zhang C L,Wu L J,Tashiro S,et al.Oridonin induces apoptosis inhuman cervical carcinoma HeLa cells through caspase-3/ICAD path-way after altered expression of Bcl-2/Bax.Acta PharmacologicaSinic,2004,25(5),691.
- [10]Erhardt P,Coopoer G M.Activation of the CPP32 apoptotic proteaseby distinct signaling pathways with defferential sensitivity to Bcl-xL.J Boil Chem,1996,271(30):17601.
- [11]Choi B K,Choi C H,Oh H L,et al.Role of ERK activation in cis-platin-induced apoptosis in A172 human glioma cells.Neurotoxi-cology,2004,25(6):915.
- 刘艳秋
- 游松
- 田代真一
- 小野寺敏
- 池岛乔
LIU Yan-qiu~(1- 2)
- YOU Song~(2)
- TASHIRO Shin-ichi~(3)
- ONODERA Satoshi~(3)
- IKEJIMA Takashi~(1)(1.China-Japan Research Institute of Medical and Pharmaceutical Sciences
- Shenyang Pharmaceutical University
- Shenyang 110016
- China
- 2.Laboratory of Natural Product Biotechnology
- Shenyang Pharmaceutical University
- Shenyang 110016
- China
- 3.Department of Clinical and Biomedical Sciences
- Showa Pharmaceutical University
- Machida
- Tokyo 194-8543
- Japan)
- 刘艳秋
- 游松
- 田代真一
- 小野寺敏
- 池岛乔
LIU Yan-qiu~(1- 2)
- YOU Song~(2)
- TASHIRO Shin-ichi~(3)
- ONODERA Satoshi~(3)
- IKEJIMA Takashi~(1)(1.China-Japan Research Institute of Medical and Pharmaceutical Sciences
- Shenyang Pharmaceutical University
- Shenyang 110016
- China
- 2.Laboratory of Natural Product Biotechnology
- Shenyang Pharmaceutical University
- Shenyang 110016
- China
- 3.Department of Clinical and Biomedical Sciences
- Showa Pharmaceutical University
- Machida
- Tokyo 194-8543
- Japan)